NRGene Advances Mas Seeds Maize Seed Breeding with its Comprehensive Genotyping Solutions
NESS ZIONA, Israel, and HAUT-MAUCO, France, June 4, 2024 /PRNewswire/ -- NRGene (TASE: NRGN), a leading international genomics AI company, and...
Big Data
EAACI Congress Kicks Off in Valencia, Spain
Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics VALENCIA, Spain, May 31, 2024 (GLOBE NEWSWIRE) -- The EAACI...
Standout Digital Health and Medical Technology Innovators Honored in 2024 MedTech Breakthrough Awards Program
International Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) --...
AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029
USA News Group Commentary VANCOUVER, BC, April 25, 2024 /PRNewswire/ -- Across several sectors the use of artificial intelligence (AI)...
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA...
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services...
Innovaccer Launches AI Advisory Board to Drive Advances in Artificial Intelligence
Expanding its roster of technology leaders will enhance its ability to drive innovation and deliver effective AI solutions in healthcare.SAN...
ful. Health Introduces Innovative Solution to Help Group Health Plans Right-Size Healthcare Spending
DUBUQUE, IA / ACCESSWIRE / March 14, 2024 / For many, group health insurance has become more overpriced and less...
Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud
Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by the Company's recent margin...
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
Provides update on two late-stage clinical programs for BXCL501 for potential treatment of agitation Recently completed meetings with U.S. Food...
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +972-3- 9180608 I https://veidan.activetrail.biz/evogeneq4-2023 REHOVOT, Israel, March...
MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
Ethics and regulatory approvals finalized for world-first take-home use of a psychedelic medicine MB22001 in placebo-controlled trial in depressed patients...
Global Clinical Alarm Management Market Analysis/Forecast Report 2023-2028: Gradual Shift of Accountability from Payers to Providers and Growing Demand for Value-Based Healthcare
DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Global Clinical Alarm Management Market by Product (Nurse Call Systems; Connectivity/Integration Software -...
HDAI to Present at ViVE 2024 on How Clinicians Can Put AI to Work
BOSTON, Feb. 26, 2024 /PRNewswire/ -- Health Data Analytics Institute (HDAI) – a company pioneering the integration of artificial intelligence into healthcare...
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Conference call scheduled for 9:00 AM ET REHOVOT, Israel, Feb. 26, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a...
Chowis Collaborates With L’Oréal Professionnel Paris in India to Revolutionize Hair Care Service
SEOUL, SOUTH KOREA / ACCESSWIRE / February 13, 2024 / Chowis Company, a developer of skin, hair and scalp analysis...
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)
Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on...
Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences – Potential Revenues Could Total $250 Million to $300 Million
Applied UV, Inc. A Rendering of Larimar City & Resort in the Dominican Republic Max Munn, CEO of AUVI, states:...
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
CHICAGO, IL / ACCESSWIRE / January 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
CitiusTech Named a Leader and a Star Performer in Everest Group’s Payer Digital Services PEAK Matrix® Assessment 2023
PRINCETON, N.J.--(BUSINESS WIRE)--#AI--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, announced that it has been positioned as...